2021 annual financial data
Atossa Therapeutics 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -20,521,000 USD and net income was -20,606,000 USD.
Operating cash flow was -16,472,000 USD.
Get free Atossa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -20,521,000 USD
- Net income
- -20,606,000 USD
- Operating cash flow
- -16,472,000 USD